NextPharma Announces that Dr. Hermann Osterwald, Managing Director, Contract Manufacturing Services has been Reappointed to the Board and as Treasurer of APV
Surrey, UK, 26th May 2010
Surrey, UK, 26th May, 2010 - NextPharma, the leading European provider of product development, contract manufacturing and cold chain and logistics outsourcing services to the pharmaceutical and biotechnology industries, is pleased to announce that Dr Hermann Osterwald has been reappointed to the board and as Treasurer of the International Association for Pharmaceutical Technology (APV) at a recent ceremony held during TechnoPharm 2010 (International Trade Fair for Life Science Process Technologies Pharma, Food and cosmetics) in Nürnberg, Germany.
Dr. Hermann Osterwald has been a member of APV since 1977 and was originally appointed to the APV board and as Treasurer in March 2006. Dr. Osterwald was appointed as Managing Director, Contract Manufacturing Services for NextPharma in September 2007 having previously held the role of Executive Vice President Operations since 2003. Previously he held various senior management positions in some of NextPharma’s German subsidiaries. Prior to this Dr. Osterwald gained considerable experience in a variety of senior roles within the Pharmaceutical industry dating back to 1981 including managing director for various subsidiaries of the GEHE group.
On this appointment Bill Wedlake, CEO, NextPharma Technologies commented “Dr. Hermann Osterwald is a highly valued colleague, his pharmaceutical knowledge and expertise has been of critical importance to the development of NextPharma. At NextPharma we believe that scientific innovation is central to long-term cost effective healthcare and fully support Dr Osterwald in his role at APV and as an avid supporter and promoter of all scientific development and innovation across the pharma and biotech industries”.
NextPharma develops, manufactures, packages, and distributes a broad range of products and formulations for its customers including solids, liquids and semi-solid dosage forms, antibiotics, hormones and controlled release medicines. It has an established leadership position in the high technology area of injectables manufacturing (lyophilized and liquid fill), with particular expertise in product development and manufacture of oncology medicines.
Contact:
Franck Latrille
Chief Executive Officer
NextPharma Technologies Holding Limited
Tel +44 (0) 1483 479 120
Notes to Editors:
About NextPharma
NextPharma Technologies, headquartered in the UK and founded in 2000, is a world class outsourcing partner to the pharmaceutical and biotechnology industry.
We offer a full range of services from early phase product development, through clinical trial packaging (Phases I through III) to high volume commercial manufacturing. We are a world leader in lyophilization, sterile fill finish and pellet technologies and in specialist product manufacturing including cytotoxics, hormones, penicillins, cephalosporins and controlled drugs. Our sterile development and production offers a full range of drug delivery technologies including pre-filled syringes, vials and ampoules. Additionally we have significant expertise in paediatric drug formulation, development and manufacture.
We operate globally with seven product development centres, seven manufacturing plants and six temperature controlled storage and distribution sites across Europe and North America, supplying customers in North America, Europe and Japan.
.
We have 1,200 employees dedicated to serving over 200 customers world wide and a customer base, which includes many of the world’s leading pharmaceutical, specialty pharma and biotech companies.
We have a proven track record in almost all pharmaceutical technologies and product forms and in addition to the specialist areas above have capabilities in solids, semi-solids, liquids, sprays and dry dosage form technologies.
All of our sites are either FDA inspected, in the process of upgrade for inspection or targeted for upgrade for inspection.
About APV
APV is the pharmaceutical association in German speaking countries and in Europe, for all involved in the field of pharmaceuticals providing a platform for sharing and spreading scientific information related to pharmaceuticals. Every year APV conducts some 100 programmes of various types, ranging from international conferences through expert meetings and workshops for practicing pharmaceutical scientists and pharmacists to botanical expeditions.